Bioequivalence Study of Valsatril Tablet Versus Entresto® Sacubitril/Valsartan 24/26 mg Tablet.

NCT07746908 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Valsatril®
DRUG: Entresto®

Sponsor

Center for Bioequivalence Studies and Clinical Research

Collaborators

[object Object]